• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WOMANCARE GLOBAL IPAS MANUAL VACUUM ASPIRATION (MVA); IPAS EASY GRIP CANNULAE; VACUUM ABORTION SYSTEM; CANNULA-SUCTION, PRODUCT CODE HHI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WOMANCARE GLOBAL IPAS MANUAL VACUUM ASPIRATION (MVA); IPAS EASY GRIP CANNULAE; VACUUM ABORTION SYSTEM; CANNULA-SUCTION, PRODUCT CODE HHI Back to Search Results
Model Number MMKSU
Device Problem Physical Resistance (2578)
Patient Problems Abdominal Pain (1685); Perforation (2001)
Event Type  Injury  
Manufacturer Narrative
On 21 may 2017 - follow-up (from wcg requested information to distributor, sent on 28 april 2017): product information.Specific devices involved in the procedure - part number and/or product name of aspirator and cannula used.Wcg: are these devices available for return and evaluation? (b)(4): has already discarded.Wcg: are photos of the devices used in the procedure available? (b)(4): impossible because has discarded.Status of device prior to use.Wcg age of devices? (b)(4): no record.Wcg: condition of devices prior and after use (e.G.Breaks, brittle, etc.)? (b)(4): nothing recognize any problem of the device.Wcg: device preparation performed? (b)(4): yes, checked the product before use.Device performance during procedure wcg: any issues encountered? (b)(4): recognized a little bit difficult to insert the cannula.Wcg: did aspiration of any pregnancy tissue occur? (b)(4): aspirator didn't move when the doctor tried to move longitudinal direction under the suction pressure condition.Wcg: was the procedure completed with aspiration (manual or electric) or if not, how was the procedure completed? (b)(4): when moved the aspirator back and forth with the transabdominal ultrasound, the uterine tissue also moved together, so it was suspected uterine puncture and stopped surgery.Patient/procedure information.Wcg: name, title, address, phone of practitioner who performed procedure? (b)(4): no.Wcg: experience of practitioner performing procedure = 2 yrs? (b)(4): two year experiences of obstetrics and gynecology.(if include medical intern, 4 years experiences).Wcg: number of years of experience performing mva procedure) = < 1 yr, first time.(b)(4): first try for mva.Wcg: type of mva training provided? (b)(4): no operation experience.Learning from watching.Wcg: was dr.(b)(6) the physician who performed the mva procedure? if no - please kindly provide his position and role to the hospital.(b)(4): dr.(b)(6) didn't operate the treatment.His position is supervisor.· wcg: name, address and phone of facility where event occurred? (b)(4): has already informed (note: provided in initial report).Wcg: number of previous pregnancies = 1? (b)(4): has already informed.(note: provided in initial report).Wcg: gestational age of pregnancy = 6-7 weeks? (b)(4): not exactly, but remember such like this.Wcg: date of initial mva procedure performed? (b)(4): not remember, need to confirm the clinical records.Wcg: how many passes into the uterus occurred during the procedure? (b)(4): one or two.Wcg: what treatment/diagnostic testing was performed prior to first surgery (e.G.Anesthesia, ultrasound, ct scan, x-ray)? (b)(4): performed transvaginal sonography and missed at abortion diagnosis.Ketalar was used for anesthesia.Wcg: what treatment/diagnostic testing was performed after event? (b)(4): repair surgery and uterine content elimination were performed under the laparoscopic surgery.Because perforation in the body part of the uterine front wall under was recognized.Wcg: diagnostic test/procedure performed for verification of perforation? (b)(4): performed contrast ct and transabdominal ultrasound.Wcg: location in the uterus of the perforation? (anterior/posterior/fundal/midline/lateral).(b)(4): it was slightly from the uterus bottom of the uterine front wall.Wcg: date of procedure to resolve perforation? (b)(4): same day of mva operation.Wcg: procedure performed to resolve perforation? (b)(4): laparoscopic uterine perforation surgery.Wcg: medication administered? (b)(4): antibiotics and uterine contraction agent (methyl ergometrin) after operation.Wcg: date of release and follow-up? (b)(4): about three days after operation.** wcg - comment from wcg qa: further investigation/evaluation of the reported mmksu devices (aspirator, cannulae) used in the mva procedure could not be performed as the product was not available for return/evaluation, and lot number information was not provided.Device malfunction does not appear to be the cause of the adverse event.Device was not made available.
 
Event Description
On 20 april 2017 - initial report received by womancare global (wcg) womancare global was notified by (b)(4) distributor of ipas manual aspirator (mva), ipas easy grip and denniston dilators, (b)(4), of an adverse event that occurred during a mva procedure on (b)(6) 2017 (exact date was not provided) at (b)(6) hospital in (b)(6).The distributor received the adverse event report from dr.(b)(6), ob-gyn supervisor, at their vendor's booth during the (b)(6).Dr.(b)(6) reported that a suspected intra-operative perforation had occurred during a mva procedure to a (b)(6) patient with 6-7 weeks gestation.Distributor ((b)(4)) report (as received on 20 april 2017): age at 30's.1 maternity (cesarean section performed at pelvic position several years ago).This time diagnosed as missed abortion at 6 to 7 w upon natural pregnancy.Surgery was performed by intravenous anesthesia with ketalar® (ketamine hydrochloride).In the preoperative usg, the lower uterine segment is somewhat thinned, and the uterus posterior flexion was strong.Cervical expansion with dilasoft® prior to the operation.The surgery was performed under transabdominal ultrasound.The surgeon is the second year specialist of obstetrics and gynecology and he performed mva for the first time.Cervix was dilated with the denniston dilators in the mva kit.Then 8 mm or 9 mm cannulas was used.It seems there was a resistance when inserting but the surgeon continue inserting.When a negative pressure was applied, the cannula totally stuck and perforation was suspected.(in the subsequent consideration, it was determined that the cannula was aspirating the mesentery and this is why the surgeon lost motion of the cannula).Due to suspecting intra-operative perforation, mva surgery was discontinued and observed while.As abdominal pain persistence + ascetic fluid retention was confirmed uterine perforation was diagnosed.On the same day laparoscopically, uterine puncture repair operation + d&c was completed.The postoperative course was good and the patient was discharged the hospital on the fourth day of laparoscopic surgery.The woman's period is resumed and the recovery is well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IPAS MANUAL VACUUM ASPIRATION (MVA); IPAS EASY GRIP CANNULAE
Type of Device
VACUUM ABORTION SYSTEM; CANNULA-SUCTION, PRODUCT CODE HHI
Manufacturer (Section D)
WOMANCARE GLOBAL
12400 high bluff drive
suite 600
san diego CA 92130
Manufacturer (Section G)
PACIFIC HOSPITAL SUPPLY CO., LTD.
no. 19, tzi-chiang road
torng-lo industrial district
miaoli, miaoli 366
TW   366
Manufacturer Contact
kelly culwell
12400 high bluff drive
suite 600
san diego, CA 92130
8583144025
MDR Report Key6589552
MDR Text Key75924570
Report Number3008007615-2017-00002
Device Sequence Number1
Product Code HHI
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial
Report Date 05/23/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberMMKSU
Device Catalogue NumberMMKSU
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age30 YR
-
-